These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26462362)

  • 41. Preface. Infections and rheumatic diseases.
    Espinoza LR
    Rheum Dis Clin North Am; 2009 Feb; 35(1):xi-xii. PubMed ID: 19480993
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of rheumatoid arthritis with biologics.
    Panayi GS
    Schweiz Med Wochenschr Suppl; 1996; 80():22S-23S. PubMed ID: 8795120
    [No Abstract]   [Full Text] [Related]  

  • 43. Advances. A new era in treating arthritis.
    Emery P
    Health Serv J; 2009 Dec; 119(6186):suppl 1-2. PubMed ID: 20128083
    [No Abstract]   [Full Text] [Related]  

  • 44. [Association of nopoxamine lauryl-sulfate, galactane sulfate and aluminium basic amino-acetate in the treatment of gastro-duodenal pains].
    Parturier-Albot M; Veyne S
    Actual Hepatogastroenterol (Paris); 1969; 5(5):B231-5. PubMed ID: 4188601
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials.
    Strand V; Scott DL; Panayi GS
    J Rheumatol; 1994 Aug; 21(8):1390-2. PubMed ID: 7983635
    [No Abstract]   [Full Text] [Related]  

  • 46. An anthelminthic trial with "Nilverm" against gastro-intestinal nematodes of sheep.
    Hiregoudar LS
    Indian Vet J; 1970 Jan; 47(1):16-8. PubMed ID: 5462212
    [No Abstract]   [Full Text] [Related]  

  • 47. Expanding role of biologic agents in rheumatoid arthritis.
    Kalden JR
    J Rheumatol Suppl; 2002 Nov; 66():27-37. PubMed ID: 12435166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of biologicals in early rheumatoid arthritis.
    Haque UJ; Bathon JM
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):179-89. PubMed ID: 15588978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Adequate therapy of intestinal dysbacteriosis in children].
    Bel'mer SV; Gasilina TV
    Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015
    [No Abstract]   [Full Text] [Related]  

  • 50. Preface. Unlocking nature through Chemistry.
    Neidle S
    Bioorg Med Chem; 2014 Aug; 22(16):4355. PubMed ID: 25023541
    [No Abstract]   [Full Text] [Related]  

  • 51. Cardiovascular friendly natural products: a promising approach in the management of CVD.
    Shukla SK; Gupta S; Ojha SK; Sharma SB
    Nat Prod Res; 2010 May; 24(9):873-98. PubMed ID: 20461632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological agents in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1992 Jan; 32():85-8; discussion 88-91. PubMed ID: 1613738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Colibacterin in intestinal diseases associated with dysbacteriosis].
    Pospelova VV; D'iakova EI; Vil'shanskaia FL
    Klin Med (Mosk); 1970 May; 48(5):59-61. PubMed ID: 4915001
    [No Abstract]   [Full Text] [Related]  

  • 54. Developments in rheumatoid arthritis.
    Thomas J; Scott D
    Practitioner; 2006 Jun; 250(1683):31, 33, 35 passim. PubMed ID: 16856503
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experience in the use of bifidumbacterin in children with prolonged intestinal diseases].
    Zatsepin IuK; D'iakova EI; Goncharova GI; Liannaia AM; Kozlova EP; Aleksandrova AM; Kozhevitskaia OB
    Pediatriia; 1970 May; 49(5):62-4. PubMed ID: 5447911
    [No Abstract]   [Full Text] [Related]  

  • 56. Use of biologic agents in rheumatoid arthritis: introduction.
    Silman AJ
    Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv3-4. PubMed ID: 21859703
    [No Abstract]   [Full Text] [Related]  

  • 57. BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis.
    Panayi G; Corrigall V
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S16-7. PubMed ID: 15309771
    [No Abstract]   [Full Text] [Related]  

  • 58. Emerging diseases of the gastrointestinal tract. Preface.
    Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2009; 23(1):1-2. PubMed ID: 19258181
    [No Abstract]   [Full Text] [Related]  

  • 59. [Application of colibacterin to prevent intestinal diseases in nurseries].
    Borodinova AA
    Vopr Okhr Materin Det; 1970 Mar; 15(3):90-1. PubMed ID: 4910769
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiovascular protection by natural products.
    Caballero-George C
    Planta Med; 2015 Jun; 81(8):623. PubMed ID: 26039177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.